HCMV microinfections in inflammatory diseases and cancer

Journal of Clinical Virology

Volumn 41, Issue 3, 2008, Pages 218-223

  Söderberg Nauclér, Cecilia ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoimmune diseases; Cancer; Cardiovascular diseases; HCMV; Inflammatory disease; TNF

Indexed keywords

CD28 ANTIGEN; VIRUS PROTEIN;

ARTICLE; CARDIOVASCULAR DISEASE; CD4+ T LYMPHOCYTE; CYTOMEGALOVIRUS INFECTION; GLIOBLASTOMA; HUMAN; HUMAN CYTOMEGALOVIRUS; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; NEOPLASM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIRUS REACTIVATION; VIRUS REPLICATION;

ANIMALS; CARDIOVASCULAR DISEASES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; INFLAMMATION; NEOPLASMS; VIRUS ACTIVATION;

EID: 39149135191     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.11.009     Document Type: Article

References (50)

1. Appay V., Dunbar P.R., Callan M., Klenerman P., Gillespie G.M., Papagno L., et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8 (2002) 379-385
2. Bruggeman C.A. Does cytomegalovirus play a role in atherosclerosis?. Herpes 7 (2000) 51-54
3. Carlquist J.F., Muhlestein J.B., Horne B.D., Hart N.I., Lim T., Habashi J., et al. Cytomegalovirus stimulated mRNA accumulation and cell surface expression of the oxidized LDL scavenger receptor, CD36. Atherosclerosis 177 (2004) 53-59
4. Cinatl Jr. J., Cinatl J., Vogel J.U., Kotchetkov R., Driever P.H., Kabickova H., et al. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells. Cancer Res 58 (1998) 367-372
5. Cinatl J., Scholz M., Kotchetkov R., Vogel J.U., and Doerr H.W. Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology. Trends Mol Med 10 (2004) 19-23
6. Cinatl Jr. J., Scholz M., and Doerr H.W. Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation. Med Res Rev 25 (2005) 167-185
7. Cobbs C.S., Harkins L., Samanta M., Gillespie G.Y., Bharara S., King P.H., et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62 (2002) 3347-3350
8. Cobbs C., Harkins L.E., Klemm K., Britt W.J., Wang W., and Kirby I.B. Detection of human cytomegalovirus expression in normal and neoplastic breast epithelium. Proceedings of the 11th international CMV and betaherpes workshop (2007) abstract S6-0-P1
9. Craigen J.L., Yong K.L., Jordan N.J., MacCormac L.P., Westwick J., Akbar A.N., et al. Human cytomegalovirus infection up-regulates interleukin-8 gene expression and stimulates neutrophil transendothelial migration. Immunology 92 (1997) 138-145
10. Decrion A.Z., Varin A., Drobacheff C., Estavoyer J.M., and Herbein G. A subset of functional effector-memory CD8+ T lymphocytes in human immunodeficiency virus-infected patients. Immunology 121 (2007) 405-415
11. Docke W.D., Prosch S., Fietze E., Kimel V., Zuckermann H., Klug C., et al. Cytomegalovirus reactivation and tumour necrosis factor. Lancet 343 (1994) 268-269
12. Fasth A.E., Cao D., van Vollenhoven R., Trollmo C., and Malmstrom V. CD28nullCD4+ T cells-characterization of an effector memory T-cell population in patients with rheumatoid arthritis. Scand J Immunol 60 (2004) 199-208
13. Fasth AER, Dastmalchi M, Rahbar A, Salomonsson S, Lindroos E, Nennesmo I, et al., submitted for publication. Muscle infiltrating T cells in rheumatic dermatomyositis and polymyositis are predominantly CD28null effector T cells associated with cytomegalovirus infection.
14. Fietze E., Prosch S., Reinke P., Stein J., Docke W.D., Staffa G., et al. Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor. Transplantation 58 (1994) 675-680
15. Fletcher J.M., Vukmanovic-Stejic M., Dunne P.J., Birch K.E., Cook J.E., Jackson S.E., et al. Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol 175 (2005) 8218-8225
16. Haagmans B.L., Stals F.S., van der Meide P.H., Bruggeman C.A., Horzinek M.C., and Schijns V.E. Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus. J Virol 68 (1994) 2297-2304
17. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
18. Harkins L., Volk A.L., Samanta M., Mikolaenko I., Britt W.J., Bland K.I., et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 360 (2002) 1557-1563
19. Hong Q, Strååt K, Rahbar A, Wan M, Söderberg-Nauclér C, Haeggström JZ. Human CMV infection induces 5-lipoxygenase expression and leukotriene B4 production in vascular smooth muscle cells. J Exp Med, in press.
20. Hooper M., Kallas E.G., Coffin D., Campbell D., Evans T.G., and Looney R.J. Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis. J Rheumatol 26 (1999) 1452-1457
21. Huang G., Yan Q., Wang Z., Chen X., Zhang X., Guo Y., et al. Human cytomegalovirus in neoplastic cells of Epstein-Barr virus negative Hodgkin's disease. Int J Oncol 21 (2002) 31-36
22. Johnson J.L., George S.J., Newby A.C., and Jackson C.L. Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc Natl Acad Sci USA 102 (2005) 15575-15580
23. Kaariainen L., Klemola E., and Paloheimo J. Rise of cytomegalovirus antibodies in an infectious-mononucleosis-like syndrome after transfusion. Br Med J 5498 (1966) 1270-1272
24. Kern F., Surel I.P., Brock C., Freistedt B., Radtke H., Scheffold A., et al. T-cell epitope mapping by flow cytometry. Nat Med 4 (1998) 975-978
25. Labalette M., Salez F., Pruvot F.R., Noel C., and Dessaint J.P. CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: expansion of an uncommon CD8+CD57- subset and its progressive replacement by CD8+CD57+T cells. Clin Exp Immunol 95 (1994) 465-471
26. Lamprecht P., and Gross W.L. Current knowledge on cellular interactions in the WG-granuloma. Clin Exp Rheumatol 25 (2007) S49-S51
27. Miller W., Flynn P., McCullough J., Balfour Jr. H., Goldman A., Haake R., et al. Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood 67 (1986) 1162-1167
28. Moss P., and Khan N. CD8(+) T-cell immunity to cytomegalovirus. Hum Immunol 65 (2004) 456-464
29. Nast C.C., Wilkinson A., Rosenthal J.T., Barba L., Bretan P.N., Beaumont P., et al. Differentiation of cytomegalovirus infection from acute rejection using renal allograft fine needle aspirates. J Am Soc Nephrol 1 (1991) 1204-1211
30. Prosch S., Staak K., Stein J., Liebenthal C., Stamminger T., Volk H.D., et al. Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB. Virology 208 (1995) 197-206
31. Prosch S., Wendt C.E., Reinke P., Priemer C., Oppert M., Kruger D.H., et al. A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation. Virology 272 (2000) 357-365
32. Prosch S., Heine A.K., Volk H.D., and Kruger D.H. CCAAT/enhancer-binding proteins alpha and beta negatively influence the capacity of tumor necrosis factor alpha to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by nuclear factor kappaB during monocyte differentiation. J Biol Chem 276 (2001) 40712-40720
33. Rahbar A., and Soderberg-Naucler C. Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation. J Virol 79 (2005) 2211-2220
34. Rahbar A., Bostrom L., Lagerstedt U., Magnusson I., Soderberg-Naucler C., and Sundqvist V.A. Evidence of active cytomegalovirus infection and increased production of IL-6 in tissue specimens obtained from patients with inflammatory bowel diseases. Inflamm Bowel Dis 9 (2003) 154-161
35. Reeves M.B., MacAry P.A., Lehner P.J., Sissons J.G., and Sinclair J.H. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci USA 102 (2005) 4140-4145
36. Ricart M.J., Malaise J., Moreno A., Crespo M., and Fernandez-Cruz L. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant 20 Suppl 2 (2005) ii25-ii32 ii62
37. Samanta M., Harkins L., Klemm K., Britt W.J., and Cobbs C.S. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol 170 (2003) 998-1002
38. Soderberg-Naucler C. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?. J Intern Med 259 (2006) 219-246
39. Soderberg-Naucler C. Human cytomegalovirus persists in its host and attacks and avoids elimination by the immune system. Crit Rev Immunol 26 (2006) 231-264
40. Soderberg-Naucler C., Fish K.N., and Nelson J.A. Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J Clin Invest 100 (1997) 3154-3163
41. Soderberg-Naucler C., Fish K.N., and Nelson J.A. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91 (1997) 119-126
42. Soderberg-Naucler C., Streblow D.N., Fish K.N., Allan-Yorke J., Smith P.P., and Nelson J.A. Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J Virol 75 (2001) 7543-7554
43. Straat K, de Klark R, Gredmark S, Eriksson P, Soderberg-Naucler C, submitted for publication. Infection by human cytomegalovirus alters the MMP-9/TIMP-1 balance in human macrophages.
44. Streblow D.N., Soderberg-Naucler C., Vieira J., Smith P., Wakabayashi E., Ruchti F., et al. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 99 (1999) 511-520
45. Streblow D.N., Orloff S.L., and Nelson J.A. Acceleration of allograft failure by cytomegalovirus. Curr Opin Immunol (2007)
46. Thewissen M., Somers V., Venken K., Linsen L., van Paassen P., Geusens P., et al. Analyses of immunosenescent markers in patients with autoimmune disease. Clin Immunol 123 (2007) 209-218
47. van Leeuwen E.M., Remmerswaal E.B., Vossen M.T., Rowshani A.T., Wertheim-van Dillen P.M., van Lier R.A., et al. Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J Immunol 173 (2004) 1834-1841
48. Varani S., Cederarv M., Feld S., Tammik C., Frascaroli G., Landini M.P., et al. Human cytomegalovirus differentially controls B-cell and T-cell responses through effects on plasmacytoid dendritic cells. J Immunol 179 (2007) 7767-7776
49. Vliegen I., Duijvestijn A., Grauls G., Herngreen S., Bruggeman C., and Stassen F. Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation. Microbes Infect 6 (2004) 17-24
50. Vliegen I., Herngreen S.B., Grauls G.E., Bruggeman C.A., and Stassen F.R. Mouse cytomegalovirus antigenic immune stimulation is sufficient to aggravate atherosclerosis in hypercholesterolemic mice. Atherosclerosis 181 (2005) 39-44